Shares of Integumen PLC (LON: SKIN) today rallied 42% after the company released a new personalised coronavirus breath test known as Microtox BT coupled with a complimentary digital health pass platform.
The new test, which is derived from the company’s wastewater test Microtox PD, and can analyse a person’s breath and immediately detect the spike protein of SARS-CoV-2 on persons with a high viral load.
The company confirmed that the test had completed extensive internal testing and would now be tested on the actual virus at the University of Aberdeen containment level 3 laboratory before being rolled out to a human trial of up to 3,000 participants.
Interested in investing after today’s move?
XTB gives investors access to thousands of UK and international stocks,
including fractional shares from just £1.
Explore stocks with XTB →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Want to invest in the stocks making the news?
Go from following the market to investing in it, with access to thousands
of stocks across major UK and international markets.
See available stocks →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Own the stocks you’re reading about
Invest in real shares across the UK, US and other major global markets
through XTB, all from one investment account.
Explore XTB shares →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
You don’t need to buy a whole share
Fractional shares let you invest from just £1, giving you more control
over how much you put into individual companies.
Explore fractional shares →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Want to see how XTB works first?
Explore the platform with an XTB demo account before deciding whether
you want to invest with real money.
Try the XTB demo →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
The test was developed in collaboration with Modern Water plc (“Modern Water”), Avacta Group plc (“Avacta”) and Aptamer Group Limited (“Aptamer”).
Integumen is in the process of acquiring Modern Water as covered earlier on the site.
Integumen share price
Integumen shares today rallied 42% to a high of 75.3p having surged from yesterday’s closing price of 53p.
People who read this also read:
